NewEdge Wealth LLC Sells 3,643 Shares of Danaher Corporation $DHR

NewEdge Wealth LLC lessened its position in Danaher Corporation (NYSE:DHR) by 13.7% during the first quarter, Holdings Channel reports. The institutional investor owned 23,038 shares of the conglomerate’s stock after selling 3,643 shares during the quarter. NewEdge Wealth LLC’s holdings in Danaher were worth $4,368,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the company. Main Street Group LTD acquired a new stake in shares of Danaher in the first quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new position in Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC bought a new position in Danaher in the second quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher in the fourth quarter valued at $27,000. Institutional investors own 79.05% of the company’s stock.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
• Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
• Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
• Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
• Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction

Danaher Stock Down 0.3%

Danaher stock opened at $191.87 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.52. The company’s 50-day moving average is $185.64 and its 200-day moving average is $197.04. The firm has a market capitalization of $134.88 billion, a PE ratio of 34.08, a P/E/G ratio of 2.40 and a beta of 0.79. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the business posted $0.77 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on DHR shares. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Royal Bank Of Canada raised their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday. Piper Sandler assumed coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Guggenheim dropped their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. reduced their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.